Generation of therapeutic protein variants with the human serum albumin binding capacity via site-specific fatty acid conjugation

類似資料

• Site-specific fatty acid-conjugation to prolong protein half-life in vivo
  著者:: Lim, Sung In, 等
  出版事項: (2013)
• Site-specific albumination of a therapeutic protein with multi-subunit to prolong activity in vivo
  著者:: Lim, Sung In, 等
  出版事項: (2015)
• Recombinant Peptide Production Platform Coupled with Site-Specific Albumin Conjugation Enables a Convenient Production of Long-Acting Therapeutic Peptide
  著者:: Mijeong Bak, 等
  出版事項: (2020-04-01)
• Recombinant Peptide Production Platform Coupled with Site-Specific Albumin Conjugation Enables a Convenient Production of Long-Acting Therapeutic Peptide
  著者:: Bak, Mijeong, 等
  出版事項: (2020)
• The Minimal Effect of Linker Length for Fatty Acid Conjugation to a Small Protein on the Serum Half-Life Extension
  著者:: Cho, Jinhwan, 等
  出版事項: (2020)